Titolo	Data di pubblicazione	Autore(i)
1	Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway	2010	Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M
2	WHO classification and WPSS predict posttransplantation outcome inpatients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).	2008	Alessandrino EP; Della Porta MG; Bacigalupo A; Van Lint MT; Falda M; Onida F; Bernardi M; Iori AP; Rambaldi A; Cerretti R; Marenco P; Pioltelli P; Malcovati L; Pascutto C; Oneto R; Fanin R; Bosi A; Collaboratori Levis A; Rambaldi A; Bandini G; Casini M; Rossi G; Angelucci E; Baronciani D; La Nasa G; Milone G; Mordini N; Guidi S; Bosi A; Bacigalupo A; Van Lint MT; Corradini P; Milani R; Morra E; Marenco P; Lambretenghi Deliliers G; Onida F; Ciceri F; Bernardi M; Castagna L; Narni F; Pioltelli P; Selleri C; Scimè R; Iannitto E; Musso M; Alessandrino EP; Locatelli F; Martelli F; Visani G; Di Bartolomeo P; Cavanna L; Papineschi F; Messina G; Gugliotta L; Iori AP; Foà R; Locasciulli A; Majolino I; Chiusolo P; Leone G; Arcese W; Cerretti R; Carella AM; Cascavilla N; Mazza P; Falda M; Bruno B; Boccadoro M; Fanin R; Cerno M; Raimondi R
3	VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study	2004	LEVIS A; ANSELMO AP; AMBROSETTI A; ADAMO F; BERTINI M; CAVALIERI E; GAVAROTTI P; GENUA A; LIBERATI M; PAVONE V; PIETRASANTA D; RICETTI MM; SCALABRINI DR; SALVI F; VITOLO U; ANGELUCCI E; BOCCADORO M; GALLO E; MANDELLI F
4	VelcadeTM Plus Melphalan, Prednisone, and Thalidomide (V-MPT) for Advanced Multiple Myeloma.	2005	Palumbo A; Ambrosini MT; Pregno P; Pescosta N; Callea V; Cangialosi C; Caravita T; Morabito F; Omedè P; Gay F; Avonto I; Falco P; Bringhen S; Boccadoro M
5	The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib	2018	Crisà, Elena; Cilloni, Daniela; Elli, Elena M.; Martinelli, Vincenzo; Palumbo, Giuseppe A.; Pugliese, Novella; Beggiato, Eloise; Frairia, Chiara; Cerrano, Marco; Lanzarone, Giuseppe; Marchetti, Monia; Mezzabotta, Mauro; Boccadoro, Mario; Ferrero, Dario
6	Updated analysis of CALGB (Alliance) 100104	2017	Boccadoro, Mario
7	Update on recent developments for patients with newly diagnosed multiple myeloma	2008	Palumbo A; Magarotto V; Gay F; Falco P; Bringhen S; Boccadoro M.
8	Unrelated Donor Hematopoietic Cell Transplantation after Non-Myeloablative Conditioning for Patients with High Risk Multiple Myeloma.	2006	Roberto Sorasio; Luisa Giaccone; Francesca Patriarca; Vittorio Montefusco; Stefano Guidi; Alessandro Busca; Rosanna Scime’; Giuseppe Console; Giuseppe Milone; Giuseppe Marotta; Alida Dominietto; Marcello Rotta; Michele Falda; Andrea Bacigalupo; Alberto Bosi; Paolo Corradini; Renato Fanin; Simona Pollichieni; Benedetto Bruno; and Mario Boccadoro
9	UNRELATED DONOR HAEMATOPOIETIC CELL TRANSPLANTATION AFTER TBI-BASED NON-MYELOABLATIVE CONDITIONING FOR PATIENTS WITH MULTIPLE MYELOMA	2006	Bruno B; Patriarca F. Sorasio R; Montefusco V; Guidi S; Console G; Milone M; Lauria m; Busca A; Giaccone L; Rotta M; Falda M; Corradini P; Fanin R; Storb R; Pollichieni S; Boccadoro M
10	Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma	2007	BRUNO B; SORASIO R; PATRIARCA F; MONTEFUSCO V; GUIDI S; BUSCA A; SCIME R; CONSOLE G; MILONE G; MAROTTA G; DOMINIETTO A; GIACCONE L; ROTTA M; FALDA M; BACIGALUPO A; BOSI A; CORRADINI P; FANIN R; POLLICHIENI S; BOCCADORO M
11	TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS	2003	Bringhen S; Bertola A; Cavallo F; Falco P; Massaia M; Bruno B; Barbui A; Caravita T; Musto P; Pescosta N; Rossini F; Vignetti M; Boccadoro M; Palumbo A
12	The tryptophan metabolism in the immune dysregulation of multiple myeloma	2007	Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M
13	Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma	2016	Magarotto, Valeria; Bringhen, Sara; Offidani, Massimo; Benevolo, Giulia; Patriarca, Francesca; Mina, Roberto; Falcone, Antonietta Pia; De Paoli, Lorenzo; Pietrantuono, Giuseppe; Gentili, Silvia; Musolino, Caterina; Giuliani, Nicola; Bernardini, Annalisa; Conticello, Concetta; Pulini, Stefano; Ciccone, Giovannino; Maisnar, Vladimír; Ruggeri, Marina; Zambello, Renato; Guglielmelli, Tommasina; Ledda, Antonio; Liberati, Anna Marina; Montefusco, Vittorio; Hajek, Roman; Boccadoro, Mario; Palumbo, Antonio
14	Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report	2014	Festuccia M; Giaccone L; Gay F; Brunello L; Maffini E; Ferrando F; Talamo E; Boccadoro M; Serra R; Barbui A; Bruno B
15	Treatment of newly diagnosed multiple myeloma.	2008	Palumbo A;Magarotto V;Larocca A;Bringhen S;Falco P;Di Raimondo F;Baldini L;Boccadoro M
16	Treatment of multiple myeloma: a randomized study of three different regimens.	1985	TRIBALTO M ;AMADORI S ;CANTONETTI M ;FRANCHI A ;PAPA G ;PILERI A ;BOCCADORO M ;DAMMACCO F ;VACCA A ;CENTURIONI R
17	Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.	2013	Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P.
18	Total lymphoid irradiation and antithymocyte globulin to reduce graft-versus-host disease after allografting in haematological malignancies: a GITMO experience	2011	Giaccone L; Festuccia M; Scortechini I; Gigli F; Cavattoni I; Filippi A; Carnevale-Schianca F; Partiarca F; Pini M; Risitano AM; Gallamini A; Pastano R; Casini M; Montanari M; Fanin R; Boccadoro M; Ricardi U; Bruno B; Messina G
19	Time to First Progression, but Not B2-Microglobulin, Predicts Outcome in Myeloma Patients Who Received Thalidomide as Salvage Therapy.	2006	Antonio Palumbo; Sara Bringhen; Patrizia Falco; Cecilia Rus; Federica Cavallo; Maria Teresa Ambrosini; Ilaria Avonto; Francesca Gay; Gabriele Gallone; Tommaso Caravita; Benedetto Bruno; and Mario Boccadoro
20	Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy	2007	PALUMBO A; BRINGHEN S; FALCO P; CAVALLO F; AMBROSINI MT; AVONTO I; GAY F; CARAVITA T; BRUNO B; BOCCADORO M